Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 1, 1997
[Outcome from surgery of lung cancer invading the carina]H Horinouchi, M Kohno, K Kuwabara, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|January 1, 1996
[Reconstruction of chest wall defects with autogenous ribs grafts]M Kawamura, M Seki, A Yoshizu, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1997
Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion modelY Izumi, H Sakai, T Kose, et al.Human Genetics|January 12, 2001
Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemiaT Yasuda, N Yamaguchi, K Kobayashi, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLCY Uehara, Y Takeyasu, T Yoshida, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinibH Horinouchi, B C Cho, D R Camidge, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2016
Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib studyS Kanda, K Goto, H Shiraishi, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|January 19, 2002
[Clinical analysis of surgically resected multiple primary lung cancer]H Horinouchi, M Yamamoto, T Goto, et al.Pageof 5